Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Annals of Internal Medicine
|
June 2, 2025
In VTE at high risk for recurrence, reduced- vs. full-dose DOACs did not differ for symptomatic recurrence but reduced bleeding at 37 mo
Conor Bell, Stephanie Carlin,
Cardiovascular Research
|
January 13, 2022
Advances in anticoagulation: patients with bioprosthetic heart valves
Stephanie Carlin, John Eikelboom
Expert Review of Cardiovascular Therapy
|
April 3, 2023
Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?
Stephanie Carlin, John Eikelboom
The Canadian Journal of Cardiology
|
January 12, 2024
Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation
Stephanie Carlin, John Eikelboom
Annals of Internal Medicine
|
July 31, 2023
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level
Stephanie Carlin, James Douketis
JACC. Cardiooncology
|
May 5, 2023
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients
Stephanie Carlin, Peter L Gross
Journal of Thrombosis and Haemostasis : JTH
|
September 24, 2021
Direct oral anticoagulant dose selection: Challenging cases
Stephanie Carlin, John W Eikelboom
Annals of Internal Medicine
|
October 2, 2023
In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y
Stephanie Carlin, John W Eikelboom
Pharmacological Reviews
|
February 1, 2025
Anticoagulants: From chance discovery to structure-based design
Noel Chan, Stephanie Carlin, Jack Hirsh
Journal of Thrombosis and Thrombolysis
|
July 7, 2021
The clot thickens-enhanced integration of stroke and thrombosis training
Stephanie Carlin, William Geerts, Houman Khosravani
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Annals of Internal Medicine
|
June 2, 2025
In VTE at high risk for recurrence, reduced- vs. full-dose DOACs did not differ for symptomatic recurrence but reduced bleeding at 37 mo
Conor Bell, Stephanie Carlin,
Cardiovascular Research
|
January 13, 2022
Advances in anticoagulation: patients with bioprosthetic heart valves
Stephanie Carlin, John Eikelboom
Expert Review of Cardiovascular Therapy
|
April 3, 2023
Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?
Stephanie Carlin, John Eikelboom
The Canadian Journal of Cardiology
|
January 12, 2024
Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation
Stephanie Carlin, John Eikelboom
Annals of Internal Medicine
|
July 31, 2023
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level
Stephanie Carlin, James Douketis
JACC. Cardiooncology
|
May 5, 2023
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients
Stephanie Carlin, Peter L Gross
Journal of Thrombosis and Haemostasis : JTH
|
September 24, 2021
Direct oral anticoagulant dose selection: Challenging cases
Stephanie Carlin, John W Eikelboom
Annals of Internal Medicine
|
October 2, 2023
In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y
Stephanie Carlin, John W Eikelboom
Pharmacological Reviews
|
February 1, 2025
Anticoagulants: From chance discovery to structure-based design
Noel Chan, Stephanie Carlin, Jack Hirsh
Journal of Thrombosis and Thrombolysis
|
July 7, 2021
The clot thickens-enhanced integration of stroke and thrombosis training
Stephanie Carlin, William Geerts, Houman Khosravani
Page
of 4